Newsfeeds - Spark Newswire

2 minute read

Earnings

ChemoCentryx’s Return On Capital Employed Insights

Today, 4:05 AM

According to data from Benzinga Pro, during Q2, ChemoCentryx's (NASDAQ:CCXI) reported sales totaled $11.76 million. Despite a 18.02% increase in earnings, the company posted a loss of $31.65 million.

CCXI

7 minute read

Benzinga’s Top Ratings Upgrades, Downgrades For August 10, 2022

By Benzinga Insights

Today, 4:05 AM

ALLO

22 minute read

Earnings Scheduled For August 9, 2022

By Benzinga Insights

Today, 4:05 AM

Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter.

AAIC

1 minute read

Analyst Ratings

Where ChemoCentryx Stands With Analysts

By Benzinga Insights

Today, 4:05 AM

Over the past 3 months, 4 analysts have published their opinion on ChemoCentryx (NASDAQ:CCXI) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the upcoming year.

CCXI

1 minute read

Analyst Ratings

3 Analysts Have This to Say About ChemoCentryx

By Benzinga Insights

Today, 4:05 AM

ChemoCentryx (NASDAQ:CCXI) has observed the following analyst ratings within the last quarter:

CCXI

1 minute read

HC Wainwright & Co. Downgrades ChemoCentryx to Neutral, Lowers Price Target to $52

By Benzinga Newsdesk

Today, 4:05 AM

HC Wainwright & Co. analyst Edward White downgrades ChemoCentryx (NASDAQ:CCXI) from Buy to Neutral and lowers the price target from $101 to $52.

CCXI

3 minute read

Coinbase, MercadoLibre And Some Other Big Stocks Recording Gains On Thursday

By Lisa Levin

Today, 4:05 AM

U.S. stocks closed mixed on Thursday following the release of weekly jobless claims data. Here is the list of some big stocks moving higher in the previous session.

ACA

3 minute read

Gold Tops 1,800; Alibaba Reports Upbeat Results

By Lisa Levin

Today, 4:05 AM

U.S. stocks traded mixed toward the end of trading, with the Dow Jones dropping around 75 points on Thursday

BABA

6 minute read

Why ChemoCentryx Is Trading Higher By 110%, Here Are 95 Stocks Moving In Thursday’s Mid-Day Session

By Lisa Levin

Today, 4:05 AM

Gainers InVivo Therapeutics Holdings Corp. (NASDAQ: NVIV) shares jumped 178.5% to $12.45 after gaining over 12% on Wednesday.

ACA

2 minute read

ChemoCentryx Shares Are Jumping 110% Thursday: Here’s Why

By Dylan Wechsler

Today, 4:05 AM

Shares of ChemoCentryx, Inc. (NASDAQ: CCXI) are skyrocketing Thursday following a groundbreaking announcement for the biopharmaceutical company. Why Is It Moving?

AMGN